New drug combo aims to speed stomach healing after cancer procedure
NCT ID NCT07312370
Summary
This study is testing if adding a second medication (sucralfate suspension) to the standard acid-reducing drug (esomeprazole) helps stomach ulcers heal better after a procedure to remove early-stage stomach cancer or pre-cancer. About 120 patients who have the procedure will be randomly assigned to get either the standard drug alone or the standard drug plus the extra medication for 8 weeks. Doctors will check how well the ulcers heal and look for complications like bleeding.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Hospital of Lanzhou University
Lanzhou, Gansu, 730000, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.